Ravasio, R.; Tiseo, M.; Pradelli, L.; Bellone, M.; Gervasi, A.; Coffani, M. Cost-Effectiveness Analysis of Alectinib Versus Crizotinib in First-Line Treatment of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer. Grhta 2019, 6.